{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:53:31Z","timestamp":1785545611446,"version":"3.56.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81774196"],"award-info":[{"award-number":["81774196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of shanghai Municipality of China","award":["22ZR1459200"],"award-info":[{"award-number":["22ZR1459200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-025-00276-3","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:40:36Z","timestamp":1744630836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differences in Fatty Acid Metabolism between MCDD and HFD Induced Metabolic Dysfunction-associated Fatty Liver Disease Model Mice"],"prefix":"10.1186","volume":"27","author":[{"given":"Jia-Xuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Zhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"4","key":"276_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"276_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, Ekstedt M, Esmat G, George J, Marchesini G, et al. The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? J Hepatol. 2022;76(4):771\u201380.","journal-title":"J Hepatol"},{"issue":"7","key":"276_CR3","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1097\/HC9.0000000000000200","volume":"7","author":"H Wang","year":"2023","unstructured":"Wang H, Shen H, Seo W, Hwang S. Experimental models of fatty liver diseases: status and appraisal. Hepatol Commun. 2023;7(7):e200.","journal-title":"Hepatol Commun"},{"issue":"4","key":"276_CR4","doi-asserted-by":"publisher","first-page":"1801585","DOI":"10.1002\/advs.201801585","volume":"6","author":"Y Yu","year":"2019","unstructured":"Yu Y, Cai J, She Z, Li H. Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases. Adv Sci (Weinh). 2019;6(4):1801585.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"276_CR5","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/molecules27030858","volume":"27","author":"MA Alshawsh","year":"2022","unstructured":"Alshawsh MA, Alsalahi A, Alshehade SA, Saghir SAM, Ahmeda AF, Al Zarzour RH, Mahmoud AM. A comparison of the gene expression profiles of Non-Alcoholic fatty liver disease between animal models of a High-Fat diet and Methionine-Choline-Deficient diet. Molecules. 2022;27(3):858.","journal-title":"Molecules"},{"issue":"1","key":"276_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"12","key":"276_CR7","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1111\/liv.15059","volume":"41","author":"SA Willis","year":"2021","unstructured":"Willis SA, Bawden SJ, Malaikah S, Sargeant JA, Stensel DJ, Aithal GP, King JA. The role of hepatic lipid composition in obesity-related metabolic disease. Liver Int. 2021;41(12):2819\u201335.","journal-title":"Liver Int"},{"key":"276_CR8","doi-asserted-by":"publisher","first-page":"113331","DOI":"10.1016\/j.biopha.2022.113331","volume":"153","author":"R Xu","year":"2022","unstructured":"Xu R, Pan J, Zhou W, Ji G, Dang Y. Recent advances in lean NAFLD. Biomed Pharmacother. 2022;153:113331.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"276_CR9","doi-asserted-by":"publisher","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","volume":"10","author":"MV Machado","year":"2015","unstructured":"Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, Guy CD, Diehl AM. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS ONE. 2015;10(5):e0127991.","journal-title":"PLoS ONE"},{"issue":"7","key":"276_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"2","key":"276_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","volume":"73","author":"YA Nevzorova","year":"2020","unstructured":"Nevzorova YA, Boyer-Diaz Z, Cubero FJ, Gracia-Sancho J. Animal models for liver disease - A practical approach for translational research. J Hepatol. 2020;73(2):423\u201340.","journal-title":"J Hepatol"},{"issue":"15","key":"276_CR12","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.7150\/ijbs.65044","volume":"18","author":"T Fang","year":"2022","unstructured":"Fang T, Wang H, Pan X, Little PJ, Xu S, Weng J. Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies. Int J Biol Sci. 2022;18(15):5681\u201397.","journal-title":"Int J Biol Sci"},{"issue":"8","key":"276_CR13","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41366-018-0212-0","volume":"43","author":"H Lee","year":"2019","unstructured":"Lee H, Ahn J, Shin SS, Yoon M. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor \u03b1 in high-fat-diet-fed C57BL\/6J mice. Int J Obes (Lond). 2019;43(8):1620\u201330.","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"276_CR14","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41366-018-0062-9","volume":"42","author":"M Honma","year":"2018","unstructured":"Honma M, Sawada S, Ueno Y, Murakami K, Yamada T, Gao J, Kodama S, Izumi T, Takahashi K, Tsukita S, et al. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. Int J Obes (Lond). 2018;42(9):1544\u201355.","journal-title":"Int J Obes (Lond)"},{"issue":"13","key":"276_CR15","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","volume":"172","author":"JC McGrath","year":"2015","unstructured":"McGrath JC, Lilley E. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol. 2015;172(13):3189\u201393.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"276_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xu W, Zhai T, You J, Chen Y. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway. Acta Pharm Sin B. 2019;9(4):745\u201357.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"276_CR17","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/hep.32577","volume":"76","author":"W Xu","year":"2022","unstructured":"Xu W, Cui C, Cui C, Chen Z, Zhang H, Cui Q, Xu G, Fan J, Han Y, Tang L, et al. Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. Hepatology. 2022;76(6):1794\u2013810.","journal-title":"Hepatology"},{"issue":"2","key":"276_CR18","doi-asserted-by":"publisher","first-page":"101183","DOI":"10.1016\/j.diabet.2020.07.010","volume":"47","author":"P Le\u00f3n-Mimila","year":"2021","unstructured":"Le\u00f3n-Mimila P, Villamil-Ram\u00edrez H, Li XS, Shih DM, Hui ST, Ocampo-Medina E, L\u00f3pez-Contreras B, Mor\u00e1n-Ramos S, Olivares-Arevalo M, Grandini-Rosales P, et al. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. Diabetes Metab. 2021;47(2):101183.","journal-title":"Diabetes Metab"},{"issue":"2","key":"276_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.yexcr.2017.03.032","volume":"354","author":"A Akoumi","year":"2017","unstructured":"Akoumi A, Haffar T, Mousterji M, Kiss RS, Bousette N. Palmitate mediated Diacylglycerol accumulation causes Endoplasmic reticulum stress, Plin2 degradation, and cell death in H9C2 cardiomyoblasts. Exp Cell Res. 2017;354(2):85\u201394.","journal-title":"Exp Cell Res"},{"issue":"7","key":"276_CR20","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41366-021-00811-8","volume":"45","author":"S Sanhueza","year":"2021","unstructured":"Sanhueza S, Tobar N, Cifuentes M, Quenti D, Var\u00ec R, Scazzocchio B, Masella R, Herrera K, Paredes A, Morales G, et al. Lampaya medicinalis phil. Decreases lipid-induced triglyceride accumulation and Proinflammatory markers in human hepatocytes and fat body of drosophila melanogaster. Int J Obes (Lond). 2021;45(7):1464\u201375.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"276_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int. 2021;15(1):21\u201335.","journal-title":"Hepatol Int"},{"key":"276_CR22","doi-asserted-by":"crossref","unstructured":"Yabiku K, Nakamoto K, Tsubakimoto M. Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes. J Diabetes Res 2020, 2020:1682904.","DOI":"10.1155\/2020\/1682904"},{"key":"276_CR23","doi-asserted-by":"crossref","unstructured":"Jung IR, Ahima RS, Kim SF. Time-restricted feeding ameliorates MCDD-induced steatohepatitis in mice. bioRxiv 2023.","DOI":"10.1101\/2023.11.15.567214"},{"issue":"10","key":"276_CR24","doi-asserted-by":"publisher","first-page":"8670","DOI":"10.3390\/nu7105423","volume":"7","author":"TF Tzeng","year":"2015","unstructured":"Tzeng TF, Tzeng YC, Cheng YJ, Liou SS, Liu IM. The ethanol extract from lonicera Japonica thunb. Regresses nonalcoholic steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed animal model. Nutrients. 2015;7(10):8670\u201384.","journal-title":"Nutrients"},{"issue":"5","key":"276_CR25","doi-asserted-by":"publisher","first-page":"159497","DOI":"10.1016\/j.bbalip.2024.159497","volume":"1869","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wei Y, Wang Y, Yu Z, Qin H, Zhao L, Cheng J, Shen B, Jin M, Feng H. Total flavonoids of broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signaling pathways. Biochim Biophys Acta Mol Cell Biol Lipids. 2024;1869(5):159497.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"276_CR26","doi-asserted-by":"publisher","first-page":"711763","DOI":"10.3389\/fphar.2021.711763","volume":"12","author":"YJ Chen","year":"2021","unstructured":"Chen YJ, Song HY, Zhang ZW, Chen Q, Tang ZP, Gu M. Extracts of vine tea improve Diet-Induced Non-Alcoholic steatohepatitis through AMPK-LXR\u03b1 signaling. Front Pharmacol. 2021;12:711763.","journal-title":"Front Pharmacol"},{"key":"276_CR27","doi-asserted-by":"crossref","unstructured":"Hu J, Zheng Y, Ying H, Ma H, Li L, Zhao Y. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation. Nutrients. 2022;14(18).","DOI":"10.3390\/nu14183796"},{"key":"276_CR28","doi-asserted-by":"crossref","unstructured":"Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Mitochondria matter: systemic aspects of nonalcoholic fatty liver disease (NAFLD) and diagnostic assessment of liver function by stable isotope dynamic breath tests. Int J Mol Sci 2021, 22(14).","DOI":"10.3390\/ijms22147702"},{"issue":"5","key":"276_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1017\/S1431927620024265","volume":"26","author":"M Veskovi\u0107","year":"2020","unstructured":"Veskovi\u0107 M, Labudovi\u0107-Borovi\u0107 M, Mladenovi\u0107 D, Jad\u017ei\u0107 J, Jorga\u010devi\u0107 B, Vuki\u0107evi\u0107 D, Vu\u010devi\u0107 D, Radosavljevi\u0107 T. Effect of betaine supplementation on liver tissue and ultrastructural changes in Methionine-Choline-Deficient Diet-Induced NAFLD. Microsc Microanal. 2020;26(5):997\u20131006.","journal-title":"Microsc Microanal"},{"issue":"Pt B","key":"276_CR30","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijbiomac.2018.09.151","volume":"120","author":"J Xiao","year":"2018","unstructured":"Xiao J, Wang F, Liong EC, So KF, Tipoe GL. Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3\/6 pathways in a methionine choline deficient diet steatohepatitis mouse model. Int J Biol Macromol. 2018;120(Pt B):1480\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"276_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.30066","volume":"68","author":"CJ Yu","year":"2018","unstructured":"Yu CJ, Wang QS, Wu MM, Song BL, Liang C, Lou J, Tang LL, Yu XD, Niu N, Yang X, et al. TRUSS exacerbates NAFLD development by promoting I\u03baB\u03b1 degradation in mice. Hepatology. 2018;68(5):1769\u201385.","journal-title":"Hepatology"},{"issue":"4","key":"276_CR32","doi-asserted-by":"publisher","first-page":"100651","DOI":"10.1016\/j.jhepr.2022.100651","volume":"5","author":"K Seedorf","year":"2023","unstructured":"Seedorf K, Weber C, Vinson C, Berger S, Vuillard L-M, Kiss A, Creusot S, Broux O, Geant A, Ilic C. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice. Jhep Rep. 2023;5(4):100651.","journal-title":"Jhep Rep"},{"key":"276_CR33","doi-asserted-by":"publisher","first-page":"1059647","DOI":"10.3389\/fcimb.2022.1059647","volume":"12","author":"L Zhu","year":"2022","unstructured":"Zhu L, Wang N, Guo G, Fan Z, Shi X, Ji X. Male zooid extracts of antheraea pernyi ameliorates non-alcoholic fatty liver disease and intestinal dysbacteriosis in mice induced by a high-fat diet. Front Cell Infect Microbiol. 2022;12:1059647.","journal-title":"Front Cell Infect Microbiol"},{"key":"276_CR34","doi-asserted-by":"publisher","first-page":"114922","DOI":"10.1016\/j.jep.2021.114922","volume":"286","author":"CZ Zhao","year":"2022","unstructured":"Zhao CZ, Jiang W, Zhu YY, Wang CZ, Zhong WH, Wu G, Chen J, Zhu MN, Wu QL, Du XL, et al. Highland barley monascus purpureus went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters. J Ethnopharmacol. 2022;286:114922.","journal-title":"J Ethnopharmacol"},{"key":"276_CR35","doi-asserted-by":"crossref","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology 2020, 161(2).","DOI":"10.1210\/endocr\/bqz046"},{"key":"276_CR36","doi-asserted-by":"publisher","first-page":"1138078","DOI":"10.3389\/fendo.2023.1138078","volume":"14","author":"T Du","year":"2023","unstructured":"Du T, Xiang L, Zhang J, Yang C, Zhao W, Li J, Zhou Y, Ma L. Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and \u03b2-oxidation. Front Endocrinol (Lausanne). 2023;14:1138078.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"276_CR37","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.celrep.2017.06.080","volume":"20","author":"J Lee","year":"2017","unstructured":"Lee J, Choi J, Selen Alpergin ES, Zhao L, Hartung T, Scafidi S, Riddle RC, Wolfgang MJ. Loss of hepatic mitochondrial Long-Chain fatty acid oxidation confers resistance to Diet-Induced obesity and glucose intolerance. Cell Rep. 2017;20(3):655\u201367.","journal-title":"Cell Rep"},{"issue":"1","key":"276_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12951-021-01108-8","volume":"19","author":"J Li","year":"2021","unstructured":"Li J, Qi J, Tang Y, Liu H, Zhou K, Dai Z, Yuan L, Sun C. A nanodrug system overexpressed CircRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis. J Nanobiotechnol. 2021;19(1):363.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"276_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","volume":"79","author":"A He","year":"2020","unstructured":"He A, Chen X, Tan M, Chen Y, Lu D, Zhang X, Dean JM, Razani B, Lodhi IJ. Acetyl-CoA derived from hepatic peroxisomal \u03b2-Oxidation inhibits autophagy and promotes steatosis via mTORC1 activation. Mol Cell. 2020;79(1):30\u2013e4234.","journal-title":"Mol Cell"},{"issue":"2","key":"276_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3390\/ijms20020308","volume":"20","author":"KM Schneider","year":"2019","unstructured":"Schneider KM, Mohs A, Kilic K, Candels LS, Elfers C, Bennek E, Schneider LB, Heymann F, Gassler N, Penders J, et al. Intestinal microbiota protects against MCD Diet-Induced steatohepatitis. Int J Mol Sci. 2019;20(2):308.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"276_CR41","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1038\/s41366-021-00944-w","volume":"45","author":"F Vahid","year":"2021","unstructured":"Vahid F, Rahmani D, Davoodi SH. The correlation between serum inflammatory, antioxidant, glucose handling biomarkers, and dietary antioxidant index (DAI) and the role of DAI in obesity\/overweight causation: population-based case-control study. Int J Obes (Lond). 2021;45(12):2591\u20139.","journal-title":"Int J Obes (Lond)"},{"key":"276_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.trsl.2020.07.008","volume":"227","author":"E Somm","year":"2021","unstructured":"Somm E, Montandon SA, Loizides-Mangold U, Ga\u00efa N, Lazarevic V, De Vito C, Perroud E, Bochaton-Piallat ML, Dibner C, Schrenzel J, et al. The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet. Transl Res. 2021;227:75\u201388.","journal-title":"Transl Res"},{"issue":"8","key":"276_CR43","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Q Wang","year":"2020","unstructured":"Wang Q, Ou Y, Hu G, Wen C, Yue S, Chen C, Xu L, Xie J, Dai H, Xiao H, et al. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice. Br J Pharmacol. 2020;177(8):1806\u201321.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"276_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41366-021-00967-3","volume":"46","author":"J Kaur","year":"2022","unstructured":"Kaur J, Kumar V, Kumar V, Shafi S, Khare P, Mahajan N, Bhadada SK, Kondepudi KK, Bhunia RK, Kuhad A, et al. Combination of TRP channel dietary agonists induces energy expending and glucose utilizing phenotype in HFD-fed mice. Int J Obes (Lond). 2022;46(1):153\u201361.","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"276_CR45","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jhepr.2021.100346","volume":"3","author":"L Parlati","year":"2021","unstructured":"Parlati L, R\u00e9gnier M, Guillou H, Postic C. New targets for NAFLD. JHEP Rep. 2021;3(6):100346.","journal-title":"JHEP Rep"},{"issue":"2","key":"276_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MOL.0b013e32835aebe7","volume":"24","author":"Z Yao","year":"2013","unstructured":"Yao Z, Zhou H, Figeys D, Wang Y, Sundaram M. Microsome-associated lumenal lipid droplets in the regulation of lipoprotein secretion. Curr Opin Lipidol. 2013;24(2):160\u201370.","journal-title":"Curr Opin Lipidol"},{"key":"276_CR47","doi-asserted-by":"publisher","first-page":"101428","DOI":"10.1016\/j.molmet.2021.101428","volume":"57","author":"H Zeng","year":"2022","unstructured":"Zeng H, Qin H, Liao M, Zheng E, Luo X, Xiao A, Li Y, Chen L, Wei L, Zhao L, et al. CD36 promotes de Novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing. Mol Metab. 2022;57:101428.","journal-title":"Mol Metab"},{"key":"276_CR48","doi-asserted-by":"publisher","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","volume":"330","author":"CY Lian","year":"2020","unstructured":"Lian CY, Zhai ZZ, Li ZF, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem Biol Interact. 2020;330:109199.","journal-title":"Chem Biol Interact"},{"issue":"5","key":"276_CR49","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","volume":"78","author":"E Lee","year":"2023","unstructured":"Lee E, Korf H, Vidal-Puig A. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023;78(5):1048\u201362.","journal-title":"J Hepatol"},{"key":"276_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fphar.2019.01134","volume":"10","author":"X Wu","year":"2019","unstructured":"Wu X, Xu N, Li M, Huang Q, Wu J, Gan Y, Chen L, Luo H, Li Y, Huang X, et al. Protective effect of Patchouli alcohol against High-Fat diet induced hepatic steatosis by alleviating Endoplasmic reticulum stress and regulating VLDL metabolism in rats. Front Pharmacol. 2019;10:1134.","journal-title":"Front Pharmacol"},{"key":"276_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13578-019-0339-2","volume":"9","author":"D Sheng","year":"2019","unstructured":"Sheng D, Zhao S, Gao L, Zheng H, Liu W, Hou J, Jin Y, Ye F, Zhao Q, Li R, et al. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell Biosci. 2019;9:77.","journal-title":"Cell Biosci"},{"key":"276_CR52","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.molmet.2021.101275","volume":"53","author":"M Serrano-Maci\u00e1","year":"2021","unstructured":"Serrano-Maci\u00e1 M, Sim\u00f3n J, Gonz\u00e1lez-Rellan MJ, Azkargorta M, Goikoetxea-Usandizaga N, Lopitz-Otsoa F, De Urturi DS, Rodr\u00edguez-Agudo R, Lachiondo-Ortega S, Mercado-Gomez M, et al. Neddylation Inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis. Mol Metab. 2021;53:101275.","journal-title":"Mol Metab"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00276-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-025-00276-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00276-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T13:01:44Z","timestamp":1744635704000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologicalproceduresonline.biomedcentral.com\/articles\/10.1186\/s12575-025-00276-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1186\/s12575-025-00276-3","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal protocol was approved by the Animal Care and Utilization Committee of Shanghai University of Traditional Chinese (authorization code: PZSHUTCM2212070004).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14"}}